Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and ...
McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. February 5, 2026 – Often in the policy realm (and especially in the health space), major reforms are ...
Jack Du has 3+ years of experience working with Brown Investment Group and 2+ years as an investment analyst. Anthony Battle is a CERTIFIED FINANCIAL PLANNER™ professional. He earned the Chartered ...
Transparency mandates require detailed disclosure of rebates, spread pricing, fees, and reimbursement methodologies, expanding plan sponsor audit rights and increasing CMS oversight of PBM reporting ...
Indiana lawmakers gave giant drugstore and insurance companies a win on Tuesday, stripping from a bill a proposal that would have taken a sledgehammer to the business operations of pharmacy benefit ...
Pharmacy Benefit Managers (PBMs) play a large role in deciding which drugs patients receive and how much they pay. Yet their fees, rebates, and contracts remain largely hidden from employers, insurers ...
Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack competitive conditions. Learnings from transparency will shape future drug pricing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’re frustrated with your pharmacy benefit manager ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results